Healthy Volunteers Clinical Trial
Official title:
Non-Invasive Study of Brain Connectivity Using Combined EEG and NIRS
Background:
- Different regions of the brain are activated when a person performs a task.
Electroencephalograms (EEGs) and near-infrared spectroscopy (NIRS) are tests that detect
changes in the brain. EEG looks at changes in electrical signals, and NIRS looks at changes
in blood flow. These tests can detect local changes in brain activity in a safe and
noninvasive way. Researchers want to study brain activity more closely by combining these
tests.
Objectives:
- To use EEG and NIRS to study brain activity during specific tasks.
Eligibility:
- Healthy volunteers at least 18 years of age.
Design:
- Participants will be screened with a physical exam and medical history.
- Participants will have between one and five testing sessions. Each session will be 1 to
2 hours long. The tests given at each session will be determined by the researchers.
- Participants will have EEG and NIRS tests, given either separately or together. During
these tests, participants will perform tasks of thinking and reasoning.
- Participants may also complete optional tests of thinking and reasoning. These tests
will be given on paper or on a computer.
Objective: To record near-infrared optical signal (NIRS) simultaneously with EEG signal and
correlate hemodynamic and neuronal responses, and to understand brain connectivity associated
with cognitive functions using combined EEG/NIRS technology
Study population: 40 healthy volunteers
Design: The study will aim to capture the dynamics of brain interactions on two different
scales by combing EEG (neuronal) and NIRS (hemodynamic) techniques. We will then correlate
the two responses to study the brain connectivity in a more comprehensive way.
Outcome Measures: graded changes in blood flow and blood oxygenation, measured with NIRS,
along with electrical signals recorded by EEG in response to different functional tasks.
Note: This study is sponsored by the Center for Neuroscience and Regenerative Medicine
(CNRM). De-identified data including imaging data sent to CNRM may be shared with outside
investigators or collaborators. This data may be used for a variety of research purposes. The
Henry M. Jackson Foundation for the Advancement for Military Medicine (HJF), USUHS, or DOD
representatives may also access data for audit purposes.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |